FindTrial
Sign In

EFFECT OF ACUTE ADMINISTRATION OF N-ACETYLCYSTEINE ON BLOOD PRESSURE OF PULMONARY ARTERIAL IN PRIMARY PULMONARY HYPERTENSION. - ND

EFFECT OF ACUTE ADMINISTRATION OF N-ACETYLCYSTEINE ON BLOOD PRESSURE OF PULMONARY ARTERIAL IN PRIMARY PULMONARY HYPERTENSION. - ND

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2009-014534-15-IT
Enrollment
Unknown
Registered
2009-09-15
Start date
2009-10-01
Completion date
Unknown
Last updated
2012-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PRIMARY PULMONARY HYPERTENSION MedDRA version: 9.1 Level: LLT Classification code 10036727

Interventions

Trade Name: FLUIMUCIL FIALE*6F 300MG/3ML Pharmaceutical Form: Solution for infusion INN or Proposed INN: Acetylcysteine Concentration unit: mg milligram(s) Concentration type: equal Concentration numb

Sponsors

AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO"
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - PRIMARY PULMONARY HYPERTENSION EVALUATED WITH RIGHT CARDIAC CATHETERISM - NEGATIVE RESULT TO VASODILATOR TEST IN RIGHT CARDIAC CATHETERISM - INFORMED WRIGHT CONSENT Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - CONTROINDICATIONS TO PULMANRY CATHETERISM - TREATMENT WITH N-ACETYLCYSTEINE DURING THE 6 MONTHS BEFORE THE STUDY - HIPERSENSITIVITY TO N-ACETYLCYSTEINE - ABSENCE OF INFORMED WRIGHT CONSENT

Design outcomes

Primary

MeasureTime frame
Secondary Objective: NON APPLICABILE;Primary end point(s): EVALUATE THE EFFECT OF THE ANTIOXIDANT THIOLIC COMPOUND N-ACETYLCYSTEINE ON PULMONARY VASODILATION IN PRESENCE OF NITRIC OXIDE ADMINISTERED BY INHALATION IN PATIENTS WITH PRIMARY PULMONARY HYPERTENSION;Main Objective: EVALUATE THE EFFECT OF THE ANTIOXIDANT THIOLIC COMPOUND N-ACETYLCYSTEINE ON PULMONARY VASODILATION IN PRESENCE OF NITRIC OXIDE ADMINISTERED BY INHALATION IN PATIENTS WITH PRIMARY PULMONARY HYPERTENSION—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026